重庆市药品监督管理局关于对重庆维尔康奇辉医药有限公司采取风险防控措施的通告

Core Viewpoint - Chongqing Weier Kangqi Hui Pharmaceutical Co., Ltd. has been found to have safety hazards, leading to a suspension of sales as a risk control measure by the Chongqing Drug Administration [2] Company Summary - Company Name: Chongqing Weier Kangqi Hui Pharmaceutical Co., Ltd. [2] - License Number: 渝AA0230793 [2] - Business Address: No. 827, Section 33, Erhuan South Road, Tangxiang Street, Dazhu District, Chongqing [2] - Warehouse Address: No. 827, Section 33, Erhuan South Road, Tangxiang Street, Dazhu District, Chongqing, covering multiple floors [2] - Business Scope: Includes chemical raw materials and their preparations, antibiotic raw materials and their preparations, biochemical products, traditional Chinese medicine, Chinese medicinal materials, Chinese medicinal pieces, biological products, protein anabolic agents, and peptide hormones [2] Regulatory Actions - The Chongqing Drug Administration has implemented a sales suspension for the company due to identified safety hazards [2] - The company is required to strictly fulfill its primary responsibility to eliminate quality safety hazards and submit a rectification report to the Chongqing Drug Administration [2] - The risk control measures will be lifted only after a re-inspection confirms compliance with the necessary conditions [2]